相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression
Ronghao Wang et al.
EUROPEAN UROLOGY (2017)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Xu-Bao Shi et al.
CANCER RESEARCH (2015)
Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer
Eleni Efstathiou et al.
EUROPEAN UROLOGY (2015)
Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer
Esra Guzel et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Dual Targeting of the Androgen Receptor and Hypoxia-Inducible Factor 1α Pathways Synergistically Inhibits Castration-Resistant Prostate Cancer Cells
Elena V. Fernandez et al.
MOLECULAR PHARMACOLOGY (2015)
MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6)
Dachuang Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
X. Yuan et al.
ONCOGENE (2014)
Mechanisms of the androgen receptor splicing in prostate cancer cells
L. L. Liu et al.
ONCOGENE (2014)
miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer
Omer Faruk Karatas et al.
PLOS ONE (2014)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary
Yangmin M. Ning et al.
CLINICAL CANCER RESEARCH (2013)
Essential Role for the Mnk Pathway in the Inhibitory Effects of Type I Interferons on Myeloproliferative Neoplasm (MPN) Precursors
Swarna Mehrotra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway
L. Adesso et al.
ONCOGENE (2013)
A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel
Liqin Du et al.
RNA BIOLOGY (2013)
Resistance Emerges to Second-Generation Antiandrogens in Prostate Cancer
William G. Nelson et al.
CANCER DISCOVERY (2013)
An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
Manav Korpal et al.
CANCER DISCOVERY (2013)
A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
James D. Joseph et al.
CANCER DISCOVERY (2013)
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2012)
Enzalutamide - A Major Advance in the Treatment of Metastatic Prostate Cancer
Nicholas J. Vogelzang
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Low Levels of Cell-Free Circulating miR-361-3p and miR-625*as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors
Carina Roth et al.
PLOS ONE (2012)
Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
Yingming Li et al.
CANCER RESEARCH (2011)
Experimental strategies for microRNA target identification
Daniel W. Thomson et al.
NUCLEIC ACIDS RESEARCH (2011)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails
Y. Niu et al.
ONCOGENE (2010)
Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development
Takeshi Ueda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Mechanisms mediating androgen receptor reactivation after castration
Xin Yuan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment
Sofia Halin et al.
PROSTATE (2007)
MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines
Carol A. Chrestensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
分享论文
